Immune checkpoint inhibitors (ICIs), a major type of cancer immunotherapy, don't do much for hospitalized cancer patients, ...

It is a useful therapy with several drawbacks that limit its effectiveness, including prolonged light sensitivity, poor tissue penetration and off-target toxicity. These drawbacks can prevent complete ...

Research at City of Hope reveals how common white button mushrooms might enhance prostate cancer treatment through surprising ...

Donors to the Sweet Relief fund also include Sony Music's Rob Stringer, Pearl Jam's Mike McCready and the George Lopez ...

The Cherokee Nation on Thursday (Feb. 13) announced an $8 million contribution to Mercy-Fort Smith for its planned cancer ...

The Cherokee Nation is giving $8 million to both the University of Oklahoma Health Stephenson Cancer Center in Tulsa and ...

A follow-up of the ShortHER trial suggests tumor-infiltrating lymphocytes (TILs) can help identify patients who may benefit ...

Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...

A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...

The family of an Auckland boy diagnosed with an aggressive form of brain cancer has had to travel to the United States for ...

The Food and Drug Administration expanded its approval of one of Pfizer's drugs, Adcetris, allowing it to be used as a treatment for certain types of lymphoma.

Morning Pointe Senior Living announces Fred Hutagaol has been selected as the recipient of the Morning Pointe Scholars Endowment scholarship at Southern Adventist University. “The Morning ... more ...